Additional file 1 of Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer

Shiming Zang (13886633)
Shuyue Ai (13886636)
Rui Yang (293531)
Pengjun Zhang (157743)
Wenyu Wu (129369)
Zhenyu Zhao (737165)
Yudan Ni (9510871)
Qing Zhang (1802)
Hongbin Sun (113935)
Hongqian Guo (717916)
Ruipeng Jia (694922)
Feng Wang (13886639)

Publication date

September 2022

DOI

10.6084/m9.figshare.21251525.v1

Abstract

Additional file 1: Table S1. Configuration settings of radiomics in the study. Table S2. The nine features selected for the predictive model construction

Extracted data

We use cookies to provide a better user experience.

Data Protection

Additional file 1 of Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer

Shiming Zang (13886633)
Shuyue Ai (13886636)
Rui Yang (293531)
Pengjun Zhang (157743)
Wenyu Wu (129369)
Zhenyu Zhao (737165)
Yudan Ni (9510871)
Qing Zhang (1802)
Hongbin Sun (113935)
Hongqian Guo (717916)
Ruipeng Jia (694922)
Feng Wang (13886639)

Open link

Publication date

September 2022

DOI

10.6084/m9.figshare.21251525.v1

Abstract

Additional file 1: Table S1. Configuration settings of radiomics in the study. Table S2. The nine features selected for the predictive model construction

Extracted data

Per Munck af Rosenschold (3996257)
Michael Zelefsky (4253701)
Aditya Apte (5096630)
Andrew Jackson (376958)
Jung Oh (3454469)
Elliot Shulman (5096636)
Neil Desai (5096627)
Margie Hunt (4253710)
Pirus Ghadjar (3538115)
Ellen Yorke (839323)
Joseph Deasy (5096633)

April 2018

Table S1. The patient characteristics, for patients experiencing PSA relapse and control, respective...

Additional file 1: of Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

B. Meller (3767254)
F. Bremmer (3767257)
C. Sahlmann (3767242)
S. Hijazi (3767245)
C. Bouter (3767263)
L. Trojan (3767251)
J. Meller (3767248)
P. Thelen (3767260)

November 2015

68 Ga-HBED-CC Radio-HPLC. Quality control of a regular Ga-HBED-CC synthesis. Radiochemical purity wa...

Additional file 2: Figure S2. of The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases

Simone Chevalier (232949)
Serge Moffett (3766309)
Eric Turcotte (64519)
Murillo Luz (3766312)
Lyne Chauvette (3766303)
Vilma Derbekyan (3766306)
Eleonora Scarlata (3766318)
Fatima Zouanat (3766300)
Armen Aprikian (183990)
Maurice Anidjar (3766315)

December 2015

PSMA expression in lymph node metastases. Sacro-iliac LNs of varying size harvested at necropsy (top...

Additional file 1 of 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer

Amir Iravani (4710744)
Michael Hofman (4054939)
Tony Mulcahy (4710741)
Scott Williams (27584)
Declan Murphy (3480083)
Bimal Parameswaran (4710747)
Rodney Hicks (4054942)

December 2017

Table S1 Characteristics and modality based results in BCR patients. Table S2 Characteristics and mo...

DataSheet_1_Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer.docx

Zhuonan Wang (7529687)
Yunxuan Li (11617234)
Anqi Zheng (10733139)
Jungang Gao (1902022)
Wang Yuan (340771)
Cong Shen (840352)
Lu Bai (343118)
Xiaoyi Duan (11153764)

November 2022

ObjectiveThe aim of this study was to evaluate the performance of Fluoride-18 (18F)-PSMA-1007-PET/CT...

Additional file 4: of Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference

Constantinos Zamboglou (364809)
Benedikt Thomann (5096807)
Khodor Koubar (5162633)
Peter Bronsert (3410321)
Tobias Krauss (5162627)
Hans Rischke (5096813)
Ilias Sachpazidis (5162624)
Vanessa Drendel (700868)
Nasr Salman (5162636)
Kathrin Reichel (5162630)
Cordula Jilg (3770989)
Martin Werner (281835)
Philipp Meyer (2042710)
Michael Bock (541214)
Dimos Baltas (5096810)
Anca Grosu (4637779)

May 2018

Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...

Additional file 1 of PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

Hui Wang (11310555)
Thomas Amiel (11310558)
Christoph Würnschimmel (11310561)
Thomas Langbein (11310564)
Katja Steiger (831771)
Isabel Rauscher (8396568)
Thomas Horn (10130)
Tobias Maurer (4896895)
Wolfgang Weber (1390167)
Hans-Juergen Wester (43799)
Karina Knorr (11310567)
Matthias Eiber (4896889)

August 2021

Additional file 1. Supplementary files. Supplementary table 1. Distribution of pT and miT. Supplemen...

Additional file 1: of Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007

Stephanie Robu (5096471)
Alexander Schmidt (68515)
Matthias Eiber (4896889)
Margret Schottelius (1816879)
Thomas GĂźnther (5096495)
Behrooz Hooshyar Yousefi (5096468)
Markus Schwaiger (10806)
Hans-JĂźrgen Wester (5096492)

April 2018

Supporting information contains the description of the chemical synthesis and radiolabeling of all c...

Additional file 1 of Clinical application of machine learning models in patients with prostate cancer before prostatectomy

Adalgisa Guerra (17938361)
Matthew R. Orton (8814047)
Helen Wang (240809)
Marianna Konidari (17938364)
Kris Maes (17938367)
Nickolas K. Papanikolaou (17938370)
Dow Mu Koh (5832332)

February 2024

Supplementary Material 1: Table S1. Standardised institutional MR image sequence parameters for Pros...

Additional file 1: of A prospective study determining and comparing the diagnostic accuracy of fluoride-PET/CT, choline-PET/CT, whole-body bone SPECT/CT and whole-body MRI for the detection of bone metastases in patients with prostate cancer

Eva Dyrberg (5826617)
Helle Hendel (5826620)
Vibeke LĂ¸gager (5826629)
Claus Madsen (5826626)
Erik Pedersen (2974491)
Bo Zerahn (263026)
Henrik Thomsen (63877)

October 2018

Table S1. NaF-PET/CT, choline-PET/CT and WB-SPECT/CT examination protocols. Table S2. WB-MRI examina...

Evaluation of 68Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving 177Lu-PSMA-617 Therapy: A Radiomics Analysis

Wolfgang Roll
Philipp Schindler
Max Masthoff
Robert Seifert
Katrin Schlack
Martin Bögemann
Lars Stegger
Matthias Weckesser
Kambiz Rahbar

July 2021

177Lutetium PSMA-617 (Lu-PSMA) therapy in patients with metastatic castration resistant prostate can...

Additional file 1 of Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria

Daniel Koehler (13931099)
Markus Sauer (16847)
Amir Karimzadeh (13931102)
Ivayla Apostolova (832129)
Susanne Klutmann (13265400)
Gerhard Adam (645067)
Sophie Knipper (13931105)
Tobias Maurer (4896895)
Christoph Berliner (13931108)

October 2022

Additional file1. Table S1. Gemini GXL 10: Cases with changes of lesion interpretation in biphasic i...

Additional file 3: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S1. Fold-change in tumor volume, 68Ga-PSMA11 uptake, and PSMA levels as assessed by flow cytom...

Additional file 1 of Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study

Ting Liu (45625)
Di Dong (580930)
Xun Zhao (1992223)
Xiao-Min Ou (17460967)
Jun-Lin Yi (9259694)
Jian Guan (288307)
Ye Zhang (132223)
Lv Xiao-Fei (17460970)
Chuan-Miao Xie (704743)
Dong-Hua Luo (495386)
Rui Sun (177521)
Qiu-Yan Chen (248096)
Lv Xing (17460973)
Shan-Shan Guo (540220)
Li-Ting Liu (719081)
Da-Feng Lin (17460976)
Yan-Zhou Chen (12152573)
Jie-Yi Lin (17460979)
Mei-Juan Luo (11656723)
Wen-Bin Yan (17460982)
Mei-Lin He (17460985)
Meng-Yuan Mao (17460988)
Man-Yi Zhu (17460991)
Wen-Hui Chen (721683)
Bo-Wen Shen (17460994)
Shi-Qian Wang (17460997)
Hai-Lin Li (628975)
Lian-Zhen Zhong (7532327)
Chao-Su Hu (2633725)
De-Hua Wu (9581697)
Hai-Qiang Mai (248095)
Jie Tian (20496)
Lin-Quan Tang (17461000)

November 2023

Additional file 1: Supplementary methods A1-A13. Figures S1-S8. Tables S1-S11. Methods A1. Inclusion...

Additional file 1: of Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control

Per Munck af Rosenschold (3996257)
Michael Zelefsky (4253701)
Aditya Apte (5096630)
Andrew Jackson (376958)
Jung Oh (3454469)
Elliot Shulman (5096636)
Neil Desai (5096627)
Margie Hunt (4253710)
Pirus Ghadjar (3538115)
Ellen Yorke (839323)
Joseph Deasy (5096633)

April 2018

Table S1. The patient characteristics, for patients experiencing PSA relapse and control, respective...

Additional file 1: of Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

B. Meller (3767254)
F. Bremmer (3767257)
C. Sahlmann (3767242)
S. Hijazi (3767245)
C. Bouter (3767263)
L. Trojan (3767251)
J. Meller (3767248)
P. Thelen (3767260)

November 2015

68 Ga-HBED-CC Radio-HPLC. Quality control of a regular Ga-HBED-CC synthesis. Radiochemical purity wa...

Additional file 2: Figure S2. of The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases

Simone Chevalier (232949)
Serge Moffett (3766309)
Eric Turcotte (64519)
Murillo Luz (3766312)
Lyne Chauvette (3766303)
Vilma Derbekyan (3766306)
Eleonora Scarlata (3766318)
Fatima Zouanat (3766300)
Armen Aprikian (183990)
Maurice Anidjar (3766315)

December 2015

PSMA expression in lymph node metastases. Sacro-iliac LNs of varying size harvested at necropsy (top...

Additional file 1 of 68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer

Amir Iravani (4710744)
Michael Hofman (4054939)
Tony Mulcahy (4710741)
Scott Williams (27584)
Declan Murphy (3480083)
Bimal Parameswaran (4710747)
Rodney Hicks (4054942)

December 2017

Table S1 Characteristics and modality based results in BCR patients. Table S2 Characteristics and mo...

DataSheet_1_Evaluation of a radiomics nomogram derived from Fluoride-18 PSMA-1007 PET/CT for risk stratification in newly diagnosed prostate cancer.docx

Zhuonan Wang (7529687)
Yunxuan Li (11617234)
Anqi Zheng (10733139)
Jungang Gao (1902022)
Wang Yuan (340771)
Cong Shen (840352)
Lu Bai (343118)
Xiaoyi Duan (11153764)

November 2022

ObjectiveThe aim of this study was to evaluate the performance of Fluoride-18 (18F)-PSMA-1007-PET/CT...

Additional file 4: of Focal dose escalation for prostate cancer using 68Ga-HBED-CC PSMA PET/CT and MRI: a planning study based on histology reference

Constantinos Zamboglou (364809)
Benedikt Thomann (5096807)
Khodor Koubar (5162633)
Peter Bronsert (3410321)
Tobias Krauss (5162627)
Hans Rischke (5096813)
Ilias Sachpazidis (5162624)
Vanessa Drendel (700868)
Nasr Salman (5162636)
Kathrin Reichel (5162630)
Cordula Jilg (3770989)
Martin Werner (281835)
Philipp Meyer (2042710)
Michael Bock (541214)
Dimos Baltas (5096810)
Anca Grosu (4637779)

May 2018

Figure S1. Dose volume histograms (DVHs) for GTV-histo, averaged for all plans and all patients. (PD...

Additional file 1 of PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy

Hui Wang (11310555)
Thomas Amiel (11310558)
Christoph Würnschimmel (11310561)
Thomas Langbein (11310564)
Katja Steiger (831771)
Isabel Rauscher (8396568)
Thomas Horn (10130)
Tobias Maurer (4896895)
Wolfgang Weber (1390167)
Hans-Juergen Wester (43799)
Karina Knorr (11310567)
Matthias Eiber (4896889)

August 2021

Additional file 1. Supplementary files. Supplementary table 1. Distribution of pT and miT. Supplemen...

Additional file 1: of Synthesis and preclinical evaluation of novel 18F-labeled Glu-urea-Glu-based PSMA inhibitors for prostate cancer imaging: a comparison with 18F-DCFPyl and 18F-PSMA-1007

Stephanie Robu (5096471)
Alexander Schmidt (68515)
Matthias Eiber (4896889)
Margret Schottelius (1816879)
Thomas GĂźnther (5096495)
Behrooz Hooshyar Yousefi (5096468)
Markus Schwaiger (10806)
Hans-JĂźrgen Wester (5096492)

April 2018

Supporting information contains the description of the chemical synthesis and radiolabeling of all c...

Additional file 1 of Clinical application of machine learning models in patients with prostate cancer before prostatectomy

Adalgisa Guerra (17938361)
Matthew R. Orton (8814047)
Helen Wang (240809)
Marianna Konidari (17938364)
Kris Maes (17938367)
Nickolas K. Papanikolaou (17938370)
Dow Mu Koh (5832332)

February 2024

Supplementary Material 1: Table S1. Standardised institutional MR image sequence parameters for Pros...

Eva Dyrberg (5826617)
Helle Hendel (5826620)
Vibeke LĂ¸gager (5826629)
Claus Madsen (5826626)
Erik Pedersen (2974491)
Bo Zerahn (263026)
Henrik Thomsen (63877)

October 2018

Table S1. NaF-PET/CT, choline-PET/CT and WB-SPECT/CT examination protocols. Table S2. WB-MRI examina...

Evaluation of 68Ga-PSMA-11 PET-MRI in Patients with Advanced Prostate Cancer Receiving 177Lu-PSMA-617 Therapy: A Radiomics Analysis

Wolfgang Roll
Philipp Schindler
Max Masthoff
Robert Seifert
Katrin Schlack
Martin Bögemann
Lars Stegger
Matthias Weckesser
Kambiz Rahbar

July 2021

177Lutetium PSMA-617 (Lu-PSMA) therapy in patients with metastatic castration resistant prostate can...

Additional file 1 of Evaluation of [68 Ga]Ga-PSMA-I&T PET/CT with additional late scans of the pelvis in prostate-specific antigen recurrence using the PROMISE criteria

Daniel Koehler (13931099)
Markus Sauer (16847)
Amir Karimzadeh (13931102)
Ivayla Apostolova (832129)
Susanne Klutmann (13265400)
Gerhard Adam (645067)
Sophie Knipper (13931105)
Tobias Maurer (4896895)
Christoph Berliner (13931108)

October 2022

Additional file1. Table S1. Gemini GXL 10: Cases with changes of lesion interpretation in biphasic i...

Additional file 3: of Preclinical evaluation of PSMA expression in response to androgen receptor blockade for theranostics in prostate cancer

Katharina Lückerath (501131)
Liu Wei (523140)
Wolfgang Fendler (5907353)
Susan Evans-Axelsson (2632642)
Andreea Stuparu (5907359)
Roger Slavik (1594090)
Christine Mona (5907362)
Jeremie Calais (5907365)
Matthew Rettig (146731)
Robert Reiter (5907368)
Ken Herrmann (711717)
Caius Radu (3400175)
Johannes Czernin (1344825)
Matthias Eiber (4896889)

December 2018

Table S1. Fold-change in tumor volume, 68Ga-PSMA11 uptake, and PSMA levels as assessed by flow cytom...

Additional file 1 of Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study

Ting Liu (45625)
Di Dong (580930)
Xun Zhao (1992223)
Xiao-Min Ou (17460967)
Jun-Lin Yi (9259694)
Jian Guan (288307)
Ye Zhang (132223)
Lv Xiao-Fei (17460970)
Chuan-Miao Xie (704743)
Dong-Hua Luo (495386)
Rui Sun (177521)
Qiu-Yan Chen (248096)
Lv Xing (17460973)
Shan-Shan Guo (540220)
Li-Ting Liu (719081)
Da-Feng Lin (17460976)
Yan-Zhou Chen (12152573)
Jie-Yi Lin (17460979)
Mei-Juan Luo (11656723)
Wen-Bin Yan (17460982)
Mei-Lin He (17460985)
Meng-Yuan Mao (17460988)
Man-Yi Zhu (17460991)
Wen-Hui Chen (721683)
Bo-Wen Shen (17460994)
Shi-Qian Wang (17460997)
Hai-Lin Li (628975)
Lian-Zhen Zhong (7532327)
Chao-Su Hu (2633725)
De-Hua Wu (9581697)
Hai-Qiang Mai (248095)
Jie Tian (20496)
Lin-Quan Tang (17461000)

November 2023

Additional file 1: Supplementary methods A1-A13. Figures S1-S8. Tables S1-S11. Methods A1. Inclusion...

Additional file 1: of Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control

Per Munck af Rosenschold (3996257)
Michael Zelefsky (4253701)
Aditya Apte (5096630)
Andrew Jackson (376958)
Jung Oh (3454469)
Elliot Shulman (5096636)
Neil Desai (5096627)
Margie Hunt (4253710)
Pirus Ghadjar (3538115)
Ellen Yorke (839323)
Joseph Deasy (5096633)

April 2018

Table S1. The patient characteristics, for patients experiencing PSA relapse and control, respective...

Additional file 1: of Alterations in androgen deprivation enhanced prostate-specific membrane antigen (PSMA) expression in prostate cancer cells as a target for diagnostics and therapy

B. Meller (3767254)
F. Bremmer (3767257)
C. Sahlmann (3767242)
S. Hijazi (3767245)
C. Bouter (3767263)
L. Trojan (3767251)
J. Meller (3767248)
P. Thelen (3767260)

November 2015

68 Ga-HBED-CC Radio-HPLC. Quality control of a regular Ga-HBED-CC synthesis. Radiochemical purity wa...

Additional file 2: Figure S2. of The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases

Simone Chevalier (232949)
Serge Moffett (3766309)
Eric Turcotte (64519)
Murillo Luz (3766312)
Lyne Chauvette (3766303)
Vilma Derbekyan (3766306)
Eleonora Scarlata (3766318)
Fatima Zouanat (3766300)
Armen Aprikian (183990)
Maurice Anidjar (3766315)

December 2015

PSMA expression in lymph node metastases. Sacro-iliac LNs of varying size harvested at necropsy (top...

Additional file 1 of Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer

Abstract

Extracted data

Additional file 1 of Development and validation of 68Ga-PSMA-11 PET/CT-based radiomics model to detect primary prostate cancer

Abstract

Extracted data

Related items

Related items